Precise Bio is at the forefront of bio-fabrication technology, utilizing an innovative 4D bio-fabrication platform that integrates tissue engineering, biomaterials, and advanced cell technologies. This platform enables the scalable and repeatable production of bio-fabricated organs and tissues from patients' own cells, addressing critical limitations in existing 3D bio-fabrication methods. The technology allows for the creation of complex tissues with high structural integrity and long-term cell viability, making it suitable for various healthcare applications, including cardiology, orthopedics, and dermatology. Precise Bio's proprietary single-cell resolution 3D printing technology enhances the precision of tissue fabrication, ensuring that the anatomical structure and functionality of natural tissues are closely mimicked.

In the ophthalmology sector, Precise Bio is pioneering solutions to address the global shortage of donor corneas. Their leading program focuses on a 3D-printed cornea graft designed to replace traditional donor tissues, offering superior quality, cell density, and transparency. The company has successfully executed animal trials for corneal transplants and is advancing a pipeline that includes additional ophthalmic applications, such as retinal patches for age-related macular degeneration and vision correction lenticules. By leveraging their robust technology platform, Precise Bio aims to transform the treatment landscape for ocular diseases and improve patient outcomes through innovative bio-fabricated solutions.

United States

Precise Bio develops and commercializes 4D bio-fabricated functional tissues and organs that can save lives and improve its quality.
We combine world-class tissue-engineering and transplantation experience with best-in-class bio-printing, to create a scalable bio-fabrication platform, that can overcome current industry challenges and make complex human organs available for transplantation.

Precise Bio

Company Details